VistaGen Therapeutics
Price & Volume
Stats
See more52W Range | $0.20-$5.14 |
Market Cap | $13.2M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $2.5M |
Revenue Growth (YoY) | 504.9% |
Gross Profit (12 Mos) | $2.5M |
Diluted EPS | -$1.70 |
News
See moreYahoo Finance • 2 months ago
VistaGen Therapeutics GAAP EPS of -$0.30 beats by $0.06, revenue of $1.48M beats by $1.31M
Yahoo Finance • 2 months ago
Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
Yahoo Finance • 4 months ago
1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't
Yahoo Finance • 5 months ago
Kuehn Law Encourages Investors of Vistagen Therapeutics, Inc. to Contact Law Firm
About
CEO | Mr. Shawn K. Singh J.D. |
CFO | Mr. Nick B. Tressler M.B.A. |
Address | 343 Allerton Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 41 |